Yes, gabapentin is dialyzable
Gabapentin can be effectively removed by hemodialysis, with approximately 35% of the dose recovered in dialysate during a single dialysis session 1, 2. This is a critical consideration for dosing in patients with end-stage renal disease.
Hemodialysis Clearance
The FDA drug label explicitly states that "gabapentin can be removed by hemodialysis" and notes that "hemodialysis has a significant effect on gabapentin elimination in anuric subjects" 1. The pharmacokinetic data are striking:
- Hemodialysis clearance: 142 mL/min (approximately 93% of dialyzer creatinine clearance) 2
- Elimination half-life during dialysis: Reduced from 132 hours (non-dialysis days in anuric patients) to approximately 3.8-4 hours during hemodialysis 1, 2
- Drug removal: Approximately 35% of the gabapentin dose is recovered in dialysate during a single hemodialysis session 2
- Post-dialysis rebound: Plasma concentrations increase approximately 30% during the first 2 hours after hemodialysis due to drug redistribution 2
Clinical Dosing Implications
The British Association of Dermatologists guidelines specifically recommend dosing gabapentin after dialysis sessions - typically 100-300 mg post-dialysis, three times per week 3. These doses are substantially lower than those used in patients with normal renal function, reflecting both reduced clearance between dialysis sessions and significant removal during dialysis.
The FDA label recommends that patients with end-stage renal disease on hemodialysis receive:
- Initial loading dose: 300-400 mg
- Maintenance: 200-300 mg after every 4 hours of hemodialysis 2
Peritoneal Dialysis
Peritoneal dialysis also removes gabapentin, though less efficiently than hemodialysis 4. With continuous automated cycling peritoneal dialysis using 2-L exchanges every 2 hours, the elimination half-life was 41.33 hours - substantially shorter than the 132 hours in anuric patients without dialysis, but much longer than the 3.8-4 hours achieved with hemodialysis 4. Gabapentin clearance by peritoneal dialysis was estimated at 94% of urea clearance 4.
Key Clinical Pitfalls
Failure to adjust gabapentin doses for dialysis status is a common and dangerous medication error 5. The case report in the medication reconciliation guideline specifically highlights inappropriate gabapentin dosing in a dialysis patient leading to adverse events including falls and hip fracture 5.
Critical considerations:
- Gabapentin requires dose reduction in all patients with renal impairment, not just those on dialysis 6, 1
- Doses must be given after dialysis sessions to avoid immediate removal 3
- The medication is classified as "high-risk" for extraction by hemodialysis 7
- Overdose in dialysis patients can cause coma, which resolves with dialysis 1
In summary, gabapentin is highly dialyzable via hemodialysis (clearance ~142 mL/min) and moderately dialyzable via peritoneal dialysis, requiring post-dialysis supplementation and careful dose adjustment to maintain therapeutic levels while avoiding toxicity.